Merck falls as brokerage cites risk
home > MSN news
Shares of Merck were down 60 cents, or 1.8 percent, to $32.85 in late-afternoon trading on the New York Stock Exchange. ... competition next year for its cholesterol fighter Zocor and for its osteoporosis treatment Fosamax beginning in 2008 ...
- link to Merck falls as brokerage cites risk -
Last update: 05/26/2005